default author photo

Shiqi Chen

Naval Medical University (SMMU)

Shanghai

China

  • Naval Medical University (SMMU)

SCHOLARLY PAPERS

1

DOWNLOADS

49

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Low-Dose Anti-VEGFR2 Therapy Promotes Anti-Tumor Immunity in Lung Adenocarcinoma by Down-Regulating the Expression of Layilin on Tumor-Infiltrating CD8 +T Cells

Number of pages: 35 Posted: 14 Mar 2022
Biaolong Yang, Biaolong Deng, Xiao-Dong Jiao, Bao-dong qin, Yi Lu, Weiqi Zhang, Yixian Guo, Shiqi Chen, Dan Li, Bin Li and Yuan-Sheng Zang
Government of the People's Republic of China - Shanghai Changzheng Hospital, Shanghai Jiao Tong University (SJTU) - Department of Microbiology and Immunology, Government of the People's Republic of China - Shanghai Changzheng Hospital, Government of the People's Republic of China - Shanghai Changzheng Hospital, Shanghai Jiao Tong University (SJTU) - Department of Ophthalmology, Shanghai Jiao Tong University (SJTU) - Department of Microbiology and Immunology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Immunology, Naval Medical University (SMMU), Shanghai Jiao Tong University (SJTU) - Department of Microbiology and Immunology, Shanghai Jiao Tong University (SJTU) - Shanghai Institute of Immunology and Government of the People's Republic of China - Department of Medical Oncology
Downloads 49 (1,074,648)

Abstract:

Loading...

Lung adenocarcinoma (LUAD), LAYN (Layilin), immunotherapy, Tumor-infiltrating exhausted CD8+T, anti-angiogenesis therapy